Properties |
Information |
PhytoCAT-ID |
PhytoCAT-1326 |
Phytochemical name or plant extracts |
Ardicrenin |
PMID |
33516453 |
Literature evidence |
Ardicrenin (6) showed significant cytotoxicity, with IC50 values of 1.17 ± 0.01, 1.19 ± 0.06, 3.52 ± 0.23, and 16.61 ± 1.02 μmol·L-1, respectively. |
IUPAC name |
(4S,5R,10S,13R,14R,20S,22S)-22-hydroxy-4,5,9,9,13,20-hexamethyl-10-[(2S,3R,4S,5S)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracosane-20-carbaldehyde |
Phytochemicals’ class or type of plant extracts |
Ethanolic extract |
Source of phytochemicals or plant Extracts |
Ardisia crenata |
|
Geographical availability |
Assam, Cambodia, China South-Central, China Southeast, Hainan, India, Japan, Korea, Laos, Malaya, Myanmar, Nansei-shoto, Philippines, Sri Lanka, Taiwan, Thailand, Tibet, Vietnam |
Plant parts |
Root |
Other cancers |
Breast cancer, Lung cancer, Liver cancer |
Target gene or protein |
NA |
Gene or Protein evidence |
NA |
Target pathways |
NA |
IC50 |
1.19 ± 0.06 µmol/L against MCF-7
16.61 ± 1.02 µmol/L against MDA-MB-231 |
Potency |
NA |
Cell line/ mice model |
A549, MCF-7, HepG2 and MDA-MB-231 |
Additional information |
NA |
PubChem ID |
3083371 |
Additional PMIDs |
NA |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:586890-1 |
Safety |
NA |